Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1978

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1978). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

This appears to be a table showing mean plasma concentrations of Dextro and Levoamphetamine in ngint. The table has columns for time periods and rows for each type of Amphetamine. However, the has made some errors and there are some confusing text that doesn't make sense. Therefore, the text contains some garbage characters and incomplete words, making it difficult to interpret.*

FDA Label Image

Label (Lbl636291978)

This is a medication called NILD, which contains a combination of Amphetamine Sulfate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Dextroamphetamine Saccharate. It comes in the form of extended-release capsules, each containing 1.25 mg of each of the four compounds mentioned. It is meant to be stored at 20-25°C and kept out of reach of children. Each container is supposed to have a child-resistant closure to ensure its safety. The package contains 100 capsules and should only be used with a prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.